Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for CLMT and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CLMT and 80,000+ other tickers.
See exactly how CLMT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CLMT and 80,000+ other tickers.
Calumet, Inc. engages in the manufacturing, formulation, and sale of specialty branded products and renewable fuel. It operates through the following segments: Specialty Products and Solutions, Montana/Renewables, Performance Brands, and Corporate. The Specialty Products & Solutions segment consists of customer-focused solutions and formulation businesses. The Montana/Renewables segment is composed of a Great Falls specialty asphalt facility and Montana Renewables facility. The Performance Brands segment includes Royal Purple, Bel-Ray, and TruFuel. The Corporate segment focuses on the general…
Here is how Calumet, Inc. (CLMT) and TXO Partners LP (TXO) have performed compared to their sector so far this year.
Bank of New York Mellon Corp cut its position in Calumet, Inc. (NASDAQ: CLMT) by 8.7% in the undefined quarter, according to its most recent disclosure with the SEC. The fund owned 192,348 shares of the oil and gas company's stock after selling 18,251 shares during the period. Bank of New York Mellon
NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Calumet, Inc. ("Calumet" or the "Company") (NASDAQ: CLMT).
INDIANAPOLIS, Sept. 3, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) ("Calumet") announced today that it plans to attend the H.C.
A federal government agency granted refining exemptions that will help the company.